Literature DB >> 23984018

Tobacco Smoking and Lung Cancer: Perception-changing facts.

Muhammad Furrukh1.   

Abstract

Tobacco smoking remains the most established cause of lung carcinogenesis and other disease processes. Over the last 50 years, tobacco refinement and the introduction of filters have brought a change in histology, and now adenocarcinoma has become the most prevalent subtype. Over the last decade, smoking also has emerged as a strong prognostic and predictive patient characteristic along with other variables. This article briefly reviews scientific facts about tobacco, and the process and molecular pathways involved in lung carcinogenesis in smokers and never-smokers. The evidence from randomised trials about tobacco smoking's impact on lung cancer outcomes is also reviewed.

Entities:  

Keywords:  Carcinogens; EML4 ALK fusion protein, human; K-Ras Gene; Lung Neoplasms; Nicotine; Receptor, Epidermal Growth Factor; Tobacco Smoking

Year:  2013        PMID: 23984018      PMCID: PMC3749017          DOI: 10.12816/0003255

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  58 in total

1.  Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Authors:  Daphne W Bell; Ira Gore; Ross A Okimoto; Nadia Godin-Heymann; Raffaella Sordella; Roseann Mulloy; Sreenath V Sharma; Brian W Brannigan; Gayatry Mohapatra; Jeff Settleman; Daniel A Haber
Journal:  Nat Genet       Date:  2005-10-30       Impact factor: 38.330

2.  Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21.

Authors:  Gary M Clark; Denni M Zborowski; Pedro Santabarbara; Keyue Ding; Marlo Whitehead; Lesley Seymour; Frances A Shepherd
Journal:  Clin Lung Cancer       Date:  2006-05       Impact factor: 4.785

3.  TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.

Authors:  Roy S Herbst; Diane Prager; Robert Hermann; Lou Fehrenbacher; Bruce E Johnson; Alan Sandler; Mark G Kris; Hai T Tran; Pam Klein; Xin Li; David Ramies; David H Johnson; Vincent A Miller
Journal:  J Clin Oncol       Date:  2005-07-25       Impact factor: 44.544

4.  Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival.

Authors:  Relin Yang; Michael C Cheung; Felipe E Pedroso; Margaret M Byrne; Leonidas G Koniaris; Teresa A Zimmers
Journal:  J Surg Res       Date:  2011-05-23       Impact factor: 2.192

5.  Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial.

Authors:  Pasi A Jänne; Xiaofei Wang; Mark A Socinski; Jeffrey Crawford; Thomas E Stinchcombe; Lin Gu; Marzia Capelletti; Martin J Edelman; Miguel A Villalona-Calero; Robert Kratzke; Everett E Vokes; Vincent A Miller
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

6.  Cigarette smoking and changes in the histopathology of lung cancer.

Authors:  M J Thun; C A Lally; J T Flannery; E E Calle; W D Flanders; C W Heath
Journal:  J Natl Cancer Inst       Date:  1997-11-05       Impact factor: 13.506

Review 7.  Lung cancer in never smokers: molecular profiles and therapeutic implications.

Authors:  Charles M Rudin; Erika Avila-Tang; Curtis C Harris; James G Herman; Fred R Hirsch; William Pao; Ann G Schwartz; Kirsi H Vahakangas; Jonathan M Samet
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

8.  Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

Authors:  Giuseppe Giaccone; Roy S Herbst; Christian Manegold; Giorgio Scagliotti; Rafael Rosell; Vincent Miller; Ronald B Natale; Joan H Schiller; Joachim Von Pawel; Anna Pluzanska; Ulrich Gatzemeier; John Grous; Judith S Ochs; Steven D Averbuch; Michael K Wolf; Pamela Rennie; Abderrahim Fandi; David H Johnson
Journal:  J Clin Oncol       Date:  2004-03-01       Impact factor: 44.544

9.  Epidermal growth factor receptor signaling in nonsmall cell lung cancer.

Authors:  Apar Kishor Ganti
Journal:  Cancer Invest       Date:  2010-06       Impact factor: 2.176

Review 10.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  30 in total

1.  Conspicuous Consumption and Sedentary Living: Is this our legacy to our children?

Authors:  Ritu Lakhtakia
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

2.  Tobacco Smoking: Facts and actions.

Authors:  Moeness M Alshishtawy
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

Review 3.  Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers.

Authors:  Courtney Schaal; Srikumar P Chellappan
Journal:  Mol Cancer Res       Date:  2014-01-07       Impact factor: 5.852

4.  Pathogenic mechanisms of lung adenocarcinoma in smokers and non-smokers determined by gene expression interrogation.

Authors:  Yunqian Hu; Guohan Chen
Journal:  Oncol Lett       Date:  2015-07-07       Impact factor: 2.967

5.  Trends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital.

Authors:  Muhammad Furrukh; Shiyam Kumar; Khawaja F Zahid; Hanan S Al-Shamly; Zainab A Al-Jabri; Ikram A Burney; Mansour S Al-Moundhri
Journal:  Sultan Qaboos Univ Med J       Date:  2017-10-10

Review 6.  Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights.

Authors:  Esther Barreiro; Víctor Bustamante; Víctor Curull; Joaquim Gea; José Luis López-Campos; Xavier Muñoz
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

7.  E-cigarette use among medical students at Qassim University: Knowledge, perception, and prevalence.

Authors:  Abdullah Almutham; Mohammed Altami; Fawzy Sharaf; Ali AlAraj
Journal:  J Family Med Prim Care       Date:  2019-09-30

Review 8.  Current clinical trials and patent update on lung cancer: a retrospective review.

Authors:  Harshul Batra; Shrikant Pawar; Dherya Bahl
Journal:  Lung Cancer Manag       Date:  2021-02-15

9.  Role of Long Noncoding RNAs in Smoking-Induced Lung Cancer: An In Silico Study.

Authors:  Lei Ge; Shishun Zhao; Jianguo Sun; Jianhua Cheng; Shaokun Wang
Journal:  Comput Math Methods Med       Date:  2022-04-30       Impact factor: 2.809

Review 10.  Acetylcholine signaling system in progression of lung cancers.

Authors:  Jamie R Friedman; Stephen D Richbart; Justin C Merritt; Kathleen C Brown; Nicholas A Nolan; Austin T Akers; Jamie K Lau; Zachary R Robateau; Sarah L Miles; Piyali Dasgupta
Journal:  Pharmacol Ther       Date:  2018-10-03       Impact factor: 13.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.